Stay on Top of New Developments at the FDA
- Posted by Mark Lookabaugh
- On September 11, 2017
Sustained regulatory compliance is a goal that should be emphasized at all pharmaceutical firms, and for that matter at any firm regulated by FDA. From a post-market perspective, FDA’s Office of Regulatory Affairs (ORA) is the organization that is most likely to interact directly with a firm. ORA comprises the group of FDA investigators, who […]
Read More